Weight loss in breast cancer patient management.

By R. Chlebowski, Erin J. Aiello, A. McTiernan. Journal of Clinical Oncology, 2002

647 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology, Physiology

View Paper: https://www.semanticscholar.org/paper/0910a53685879e7b82adfd296f8bb767505f3b65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. S. Greenfield
2. J. Slingerland
3. M. Hewitt
4. E. Stovall

In Oncology

1. Kathryn H. Schmitz
2. L. Mâsse
3. S. Duval
4. E. Stovall
5. S. Greenfield
6. J. Herrmann
7. J. Slingerland
8. E. Calle

In Physiology

1. Robert Kane
2. S. Greenfield
3. E. Calle
4. M. Hewitt
5. C. Garofalo
6. Rudolf Kaaks
7. E. Stovall
8. E. Surmacz

Citations in the corpus

• Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms (2004, background): “Studies of mortality and survival among patients with breast cancer illustrate that adiposity is associated both with reduced likelihood of survival and increased likelihood of recurrence, regardless of menopausal status and after adjustment for stage and treatmen”
• Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015, background): “Likewise, weight gain and obesity are likely to negatively affect the prognosis of breast cancer [15]; nutritional counseling should be recommended as part of survivor care for all obese patients [III, B].”
• Controlled Physical Activity Trials in Cancer Survivors: A Systematic Review and Meta-analysis (2005, background): “Sample size, mean (range) Average sample size per control group 26 (4-101) 29 (4-97) 21 (6-101)”
• Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations (2020, background): “A growing number of patients beginning their anticancer treatment are already overweight or obese,(188) and additional weight gain is a frequent complication of anticancer treatments.(189) Increasing evidence indicates that being overweight increases the risk of recurrence and reduces the likelihood”
• Nutrition and physical activity guidelines for cancer survivors (2012, background): “Indeed, given accumulating data to suggest that overweight and obesity adversely influence not only cancer-specific outcomes but also overall health and quality of life, weight management is now considered a priority standard of care for overweight women diagnosed with early stage breast cancer.(8,1”
• Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention (2017, background): “higher risk of death.(68) Nichols et al reported that each 5-”
• From cancer patient to cancer survivor : lost in transition (2006, methodology): “Of great concern is the suggestion by some studies that weight gain may increase a woman’s risk of disease recurrence and death (Chlebowski et al., 2002a; Carmichael and Bates, 2004; Dignam and Mamounas, 2004; Kroenke et al., 2005).”
• Leptin and cancer (2006, background): “Numerous studies have established that obesity is a risk factor for breast cancer development in postmenopausal women (Cleary and Maihle, 1997; Chlebowski et al., 2002; Rose et al., 2002; Stephenson and Rose, 2003).”